The Enterprise Value as of June 2026 (TTM) for Context Therapeutics Inc. (CNTX) is 73.47M

According to Context Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 73.47M. This represents a change of 13.57% compared to the average of 64.69M of the last 4 quarters.

Context Therapeutics Inc. (CNTX) Historical Enterprise Value (quarterly & annually)

How has CNTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Context Therapeutics Inc. over the last ten years is 16.66M. The current 73.47M Enterprise Value has changed 43.99% with respect to the historical average. Over the past ten years (40 quarters), CNTX's Enterprise Value was at its highest in in the March 2026 quarter at 195.14M. The Enterprise Value was at its lowest in in the December 2024 quarter at -32873644.00.

Context Therapeutics Inc. (CNTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Context Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Context Therapeutics Inc. (CNTX) Average Enterprise Value

How has CNTX Enterprise Value performed in the past?

The current Enterprise Value of Context Therapeutics Inc. (CNTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Context Therapeutics Inc. (CNTX) Enterprise Value vs. Peers

How is CNTX’s Enterprise Value compared to its peers?

Context Therapeutics Inc.’s Enterprise Value is less than Ovid Therapeutics Inc. (210.73M), less than MacroGenics, Inc. (221.70M), less than Shattuck Labs, Inc. (148.26M), greater than ImageneBio Inc (-4513289.00), less than Connect Biopharma Holdings Limited (95.83M), less than Oramed Pharmaceuticals Inc. (145.94M), less than InflaRx N.V. (85.69M), greater than Kalaris Therapeutics Inc (47.97M), less than Clene Inc. (76.31M), less than Whitehawk Therapeutics Inc (170.93M),

Build a custom stock screener for Context Therapeutics Inc. (CNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Context Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Context Therapeutics Inc. (CNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Context Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.